Bone Biologics - Warrants (13/10/2026) Current Cash

The latest current cash for BBLGW is $4.5M as of March 2026. That compares with $2.7M in the prior-year period — up 64.9% year over year. Investors often review this figure alongside Bone Biologics - Warrants (13/10/2026)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BBLGW's current cash moved from $2.7M to $4.5M — a 64.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bone Biologics - Warrants (13/10/2026)'s operating scale or balance-sheet position.

A current cash figure of $4.5M for BBLGW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting BBLGW's current cash ($4.5M), review year-over-year change from $2.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.